1 – 34 of 34
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells
(
- Contribution to journal › Article
-
Mark
Picornavirus May Be Linked to Parkinson’s Disease through Viral Antigen in Dopamine-Containing Neurons of Substantia Nigra
(
- Contribution to journal › Article
-
Mark
Inflammatory Animal Models of Parkinson's Disease
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Optimization of production and transgene expression of a retrogradely transported pseudotyped lentiviral vector
(
- Contribution to journal › Article
- 2018
-
Mark
Shifted dynamic interactions between subcortical nuclei and inferior frontal gyri during response preparation in persistent developmental stuttering
(
- Contribution to journal › Article
- 2017
-
Mark
Toxic effects of human and rodent variants of alpha-synuclein in vivo
(
- Contribution to journal › Article
-
Mark
PBB3 Imaging in Parkinsonian disorders: Evidence for binding to abnormally aggregated proteins in addition to tau proteins
2017) 21st International Congress of Parkinson's Disease and Movement Disorders In Movement Disorders 32(Suppl 2). p.585-587(
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
Pathogenic effects of alpha-synuclein: modifications and toxicity
2016)(
- Thesis › Doctoral thesis (compilation)
- 2014
-
Mark
Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease
(
- Contribution to journal › Article
- 2013
-
Mark
Variability in Neuronal Expression of Dopamine Receptors and Transporters in the Substantia Nigra
(
- Contribution to journal › Article
-
Mark
Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease
(
- Contribution to journal › Article
-
Mark
LAMP2A as a therapeutic target in Parkinson disease
(
- Contribution to journal › Debate/Note/Editorial
- 2012
-
Mark
GIRK2 Expression in Dopamine Neurons of the Substantia Nigra and Ventral Tegmental Area
(
- Contribution to journal › Article
- 2011
-
Mark
The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
(
- Contribution to journal › Article
- 2010
-
Mark
Modeling pathophysiological aspects of Parkinson’s disease: Manipulating DA handling and alpha-synuclein expression in the nigrostriatal pathway using viral vectors
(
- Thesis › Doctoral thesis (compilation)
-
Mark
The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease
(
- Contribution to journal › Article
- 2007
-
Mark
Increased catechol-O-methyltransferase activity and protein expression in OX-42-positive cells in the substantia nigra after lipopolysaccharide microinfusion
(
- Contribution to journal › Article
- 2006
-
Mark
Neurogenesis in the adult brain from ballyhoo to sobriety
2006)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Subthalamic nucleus lesioning inhibits expression and phosphorylation of c-Jun in nigral neurons in the rat's 6-OHDA model of Parkinson's disease
(
- Contribution to journal › Article
- 2005
-
Mark
Platelet-Derived Growth Factor (PDGF-BB) and Brain-Derived Neurotrophic Factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions.
(
- Contribution to journal › Article
- 2004
-
Mark
GDNF gene delivery in an animal model of Parkinson's disease. Long-term effects on intact, injured and transplanted dopamine neurons using lentiviral gene transfer
2004)(
- Thesis › Doctoral thesis (compilation)
- 2003
-
Mark
High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats
(
- Contribution to journal › Article
- 2002
-
Mark
Toward a restorative therapy for Parkinson´s disease. Studies on the functional efficacy of intracerebral fetal cell transplants and GDNF delivery.
2002)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.
(
- Contribution to journal › Article
-
Mark
Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats
(
- Contribution to journal › Article
- 2001
-
Mark
Neuropathological correlates to clinically defined dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Restorative and neuroprotective treatment strategies for Parkinson’s disease: tudies on fetal dopamine cell transplants and GDNF delivery by intracerebral injections and recombinant AAV vectors.
2001)(
- Thesis › Doctoral thesis (compilation)
- 2000
-
Mark
Chapter 8: Xenotransplantation
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 1999
-
Mark
Neuroprotective and regenerative actions of GDNF and neurturin on nigral dopamine neurons in rat models of Parkinson’s disease – Prospects for clinical use of neurotrophic factors in neurodegenerative disorders
1999)(
- Thesis › Doctoral thesis (compilation)
- 1997
-
Mark
Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats
(
- Contribution to journal › Article
- 1996
-
Mark
Effects of brain-derived neurotrophic factor on neuronal structure of dopaminergic neurons in dissociated cultures of human fetal mesencephalon
(
- Contribution to journal › Article
-
Mark
Antioxidant treatment protects striatal neurons against excitotoxic insults
(
- Contribution to journal › Article
- 1995
-
Mark
Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease
(
- Contribution to journal › Article
- 1994
-
Mark
A microtransplantation approach for cell suspension grafting in the rat Parkinson model : a detailed account of the methodology
(
- Contribution to journal › Article